Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...

AROUND half a million Brits use weight loss drugs. And that number is expected to double in the next year with the rise in ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

GLP-1 medications have been going viral for their transformative effects, but now people are raising concerns about a ...

Some people using Ozempic in clinical studies reported weight loss. Ozempic ... Association includes Wegovy in its treatment recommendations for obesity. A large review of studies compared GLP ...

Weight loss jabs such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro) have surged in popularity, becoming one ...

Clinical trials have shown that Wegovy can lead to an average weight loss of 15-18% over 68 weeks. It is approved for use in individuals with a BMI of 30 or greater or those with a BMI of 27 or ...

The South Korean office of the Danish pharmaceutical company Novo Nordisk recently requested the local authorities to permit ...

Meghan Trainor has stunned fans with her slimmer figure in 2025, but how did she lose weight? The singer has been candid ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...